Monday, December 17, 2018



Subscribe



Podcast with Ira Pastor, CEO, Bioquark Inc., about regeneration, repair and rejuvenation in humans

Posted by Elena del Valle on April 2, 2018

Ira Pastor, CEO, Bioquark

Ira Pastor, CEO, Bioquark

 

Photo: Bioquark Inc.

A podcast interview with Ira Pastor, CEO, Bioquark Inc., is available in the Podcast Section of Hispanic Marketing & Public Relations, HispanicMPR.com. During the podcast, he discusses regeneration, repair and rejuvenation with Elena del Valle, host of the HispanicMPR.com podcast.

Ira has over 30 years of experience across multiple sectors of the pharmaceutical industry including pharmaceutical commercialization, biotech drug development, managed care, distribution, and retail. According to his biography, prior to working at Bioquark he served as vice president, Business Development for drug development company Phytomedics Inc., raising $40 million of private equity, consummating over $50 million of licensing deals, and bringing a lead drug candidate from discovery stage to Phase III development.

Prior to that, he was employed by SmithKline Beecham Pharmaceuticals in sales, marketing, and business strategy positions. He has also served as vice president of Corporate Development for the pharmacy benefit management company Prescription Delivery Systems (acquired by Cigna Health Insurance). He is board member of RegenerAge SAPI de CV, the Reanima Project, and member of the World Economic Forum's Human Enhancement Council.

To listen to the interview, scroll down until you see “Podcast” on the right hand side, then select “HMPR Ira Pastor” and click on the play button below or download the MP3 file to your iPod or MP3 player to listen on the go, in your car or at home from the RSS feed. Some software will not allow flash, which may be necessary for the play button and podcast player. If that is your case, you will need to download the file to play it. To download it, click on the arrow of the recording you wish to copy and save it to disk. The podcast will remain listed in the April 2018 section of the podcast archive.